Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis

The global pandemic of COVID-19 has led to a prominent public health response, with many countries introducing highly proactive measures for screening and identifying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has gained the dubious honour as the single greatest infectiou...

Full description

Autores:
Tipo de recurso:
Article of investigation
Fecha de publicación:
2020
Institución:
Universidad de Bogotá Jorge Tadeo Lozano
Repositorio:
Expeditio: repositorio UTadeo
Idioma:
eng
OAI Identifier:
oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/14575
Acceso en línea:
https://doi.org/10.1016/S2214-109X(20)30413-7
http://hdl.handle.net/20.500.12010/14575
Palabra clave:
SARS-CoV-2
Health policies
Patients
Consider tuberculosis
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
Rights
License
Abierto (Texto Completo)
Description
Summary:The global pandemic of COVID-19 has led to a prominent public health response, with many countries introducing highly proactive measures for screening and identifying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has gained the dubious honour as the single greatest infectious cause of global mortality in 2020. Active COVID-19 disease encompasses cough, fever, fatigue, and shortness of breath among other signs and symptoms.1,2 Risk factors for severe COVID-19 disease include diabetes, chronic obstructive pulmonary disease, immune suppression, and age. Some select population demographics (people who are Black, Hispanic, or a member of another ethnic minority group), in association with overcrowded housing and homelessness, are also at risk of severe disease and mortality